BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31799179)

  • 1. YY1 Promotes Endothelial Cell-Dependent Tumor Angiogenesis in Hepatocellular Carcinoma by Transcriptionally Activating VEGFA.
    Yang W; Li Z; Qin R; Wang X; An H; Wang Y; Zhu Y; Liu Y; Cai S; Chen S; Sun T; Meng J; Yang C
    Front Oncol; 2019; 9():1187. PubMed ID: 31799179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B Virus Small Envelope Protein Promotes Hepatocellular Carcinoma Angiogenesis via Endoplasmic Reticulum Stress Signaling To Upregulate the Expression of Vascular Endothelial Growth Factor A.
    Wu SX; Ye SS; Hong YX; Chen Y; Wang B; Lin XJ; Lin X
    J Virol; 2022 Feb; 96(4):e0197521. PubMed ID: 34910612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinoma.
    Pan L; Xiao H; Liao R; Chen Q; Peng C; Zhang Y; Mu T; Wu Z
    Biomed Pharmacother; 2018 Oct; 106():68-76. PubMed ID: 29957468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis.
    Shi L; Yang F; Luo F; Liu Y; Zhang F; Zou M; Liu Q
    Tumour Biol; 2016 Sep; 37(9):12791-12803. PubMed ID: 27449032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy.
    de Nigris F; Crudele V; Giovane A; Casamassimi A; Giordano A; Garban HJ; Cacciatore F; Pentimalli F; Marquez-Garban DC; Petrillo A; Cito L; Sommese L; Fiore A; Petrillo M; Siani A; Barbieri A; Arra C; Rengo F; Hayashi T; Al-Omran M; Ignarro LJ; Napoli C
    Proc Natl Acad Sci U S A; 2010 Aug; 107(32):14484-9. PubMed ID: 20660740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma.
    Lin J; Cao S; Wang Y; Hu Y; Liu H; Li J; Chen J; Li P; Liu J; Wang Q; Zheng L
    J Exp Clin Cancer Res; 2018 Jun; 37(1):113. PubMed ID: 29866133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competitive binding between Seryl-tRNA synthetase/YY1 complex and NFKB1 at the distal segment results in differential regulation of human vegfa promoter activity during angiogenesis.
    Fu CY; Wang PC; Tsai HJ
    Nucleic Acids Res; 2017 Mar; 45(5):2423-2437. PubMed ID: 27913726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum: YY1 Promotes Endothelial Cell-Dependent Tumor Angiogenesis in Hepatocellular Carcinoma by Transcriptionally Activating VEGFA.
    Yang W; Li Z; Qin R; Wang X; An H; Wang Y; Zhu Y; Liu Y; Cai S; Chen S; Sun T; Meng J; Yang C
    Front Oncol; 2021; 11():828861. PubMed ID: 35096629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway.
    Yang X; Zhang XF; Lu X; Jia HL; Liang L; Dong QZ; Ye QH; Qin LX
    Hepatology; 2014 May; 59(5):1874-85. PubMed ID: 24259426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL24 contributes to HCC malignancy via RhoB- VEGFA-VEGFR2 angiogenesis pathway and indicates poor prognosis.
    Jin L; Liu WR; Tian MX; Jiang XF; Wang H; Zhou PY; Ding ZB; Peng YF; Dai Z; Qiu SJ; Zhou J; Fan J; Shi YH
    Oncotarget; 2017 Jan; 8(3):5135-5148. PubMed ID: 28042950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycomb YY1 is a critical interface between epigenetic code and miRNA machinery after exposure to hypoxia in malignancy.
    Infante T; Mancini FP; Lanza A; Soricelli A; de Nigris F; Napoli C
    Biochim Biophys Acta; 2015 May; 1853(5):975-86. PubMed ID: 25644713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcription factor ZFHX3 is crucial for the angiogenic function of hypoxia-inducible factor 1α in liver cancer cells.
    Fu C; An N; Liu J; A J; Zhang B; Liu M; Zhang Z; Fu L; Tian X; Wang D; Dong JT
    J Biol Chem; 2020 May; 295(20):7060-7074. PubMed ID: 32277050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial specific YY1 deletion restricts tumor angiogenesis and tumor growth.
    Liu H; Qiu Y; Pei X; Chitteti R; Steiner R; Zhang S; Jin ZG
    Sci Rep; 2020 Nov; 10(1):20493. PubMed ID: 33235311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
    Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
    J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulated Kras/YY1/ZNF322A/Shh transcriptional axis enhances neo-angiogenesis to promote lung cancer progression.
    Lin CC; Kuo IY; Wu LT; Kuan WH; Liao SY; Jen J; Yang YE; Tang CW; Chen YR; Wang YC
    Theranostics; 2020; 10(22):10001-10015. PubMed ID: 32929330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine promotes angiogenesis by activating PI3K/Akt/HIF-1α pathway and upregulating VEGF in hepatocellular carcinoma.
    Wang Z; Jiang L; Wang J; Chai Z; Xiong W
    J Gastrointest Oncol; 2021 Aug; 12(4):1761-1772. PubMed ID: 34532126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.
    El-Assal ON; Yamanoi A; Soda Y; Yamaguchi M; Igarashi M; Yamamoto A; Nabika T; Nagasue N
    Hepatology; 1998 Jun; 27(6):1554-62. PubMed ID: 9620326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of HOXC10 promotes angiogenesis in human glioma via interaction with PRMT5 and upregulation of VEGFA expression.
    Tan Z; Chen K; Wu W; Zhou Y; Zhu J; Wu G; Cao L; Zhang X; Guan H; Yang Y; Zhang W; Li J
    Theranostics; 2018; 8(18):5143-5158. PubMed ID: 30429891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CLIC1 Drives Angiogenesis in Hepatocellular Carcinoma by Modulating VEGFA.
    Wei X; Pan B; Yang M; Shu W; Khan AR; Su R; Lin H; Xu X
    Technol Cancer Res Treat; 2022; 21():15330338221106820. PubMed ID: 35722791
    [No Abstract]   [Full Text] [Related]  

  • 20. Hsp90β promoted endothelial cell-dependent tumor angiogenesis in hepatocellular carcinoma.
    Meng J; Liu Y; Han J; Tan Q; Chen S; Qiao K; Zhou H; Sun T; Yang C
    Mol Cancer; 2017 Mar; 16(1):72. PubMed ID: 28359326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.